Clinical Trial Update: Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence Areas [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating monitoring of Japanese encephalitis antibody levels in healthy populations and evaluation of immunization strategies in areas wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis

Snippet

Sponsor: Liaoning Chengda Biotechnology CO., LTD | Conditions: Japanese Encephalitis | Phase 4 | Status: ACTIVE_NOT_RECRUITING